Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.
Eileen M. Farrelly, MPH
Advertisement
Articles by Eileen M. Farrelly, MPH
Advertisement
Latest Updated Articles
- Cost of Care for Malignant and Benign Renal Masses
Published: August 12th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
3
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
4
Review Outlines Shared Pathways Between CKD, VHD
5
